Stock Analysis

Has Ingredion’s 2024 Share Price Slide Created a Long Term Opportunity?

  • If you have been wondering whether Ingredion at around $106 a share is a bargain or a value trap, you are not alone. This article is designed to walk you through that question step by step.
  • The stock is down 2.4% over the last week and 1.1% over the last month. More notably, it has slid 22.1% year to date and 24.6% over the past year, even though the 3 year and 5 year returns are still up 15.1% and 52.6% respectively.
  • Recently, investors have been digesting a mix of macro headlines around food ingredient input costs and shifting consumer demand, alongside company specific updates on productivity initiatives and portfolio optimization. Together, these have nudged sentiment away from the steady compounder narrative and toward a more cautious, wait and see stance.
  • On our framework, Ingredion scores a 3/6 valuation score. This suggests pockets of undervaluation but not an obvious slam dunk. In the next sections we will unpack what that means across multiples, discounted cash flow, and asset based views, before finishing with a more holistic way to think about the company’s true value.

Find out why Ingredion's -24.6% return over the last year is lagging behind its peers.

Approach 1: Ingredion Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a business is worth by projecting its future cash flows and then discounting them back to today, using a required rate of return. For Ingredion, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections in $.

Ingredion generated last twelve month free cash flow of about $656 million, with analysts and model assumptions pointing to $778 million in 2024. Beyond the formal forecast window, Simply Wall St extrapolates cash flows, with projected free cash flow in 2035 of roughly $277 million, still comfortably positive but lower than today as growth normalizes.

When all these future cash flows are discounted back, the model arrives at an intrinsic value of about $97.06 per share. With the stock trading around $106, the DCF suggests Ingredion is approximately 9.5% overvalued. This is close enough to consider it broadly in line with fair value rather than dramatically mispriced.

Result: ABOUT RIGHT

Ingredion is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

INGR Discounted Cash Flow as at Dec 2025
INGR Discounted Cash Flow as at Dec 2025

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Ingredion.

Approach 2: Ingredion Price vs Earnings

For consistently profitable companies like Ingredion, the price to earnings ratio is a practical way to gauge valuation, because it links what investors pay directly to the profits the business is generating today. What counts as a normal or fair PE depends on how quickly earnings are expected to grow and how risky those earnings are, with faster growing and lower risk businesses typically justifying higher multiples.

Ingredion currently trades on about 10.25x earnings, which is well below both the broader Food industry average of roughly 21.51x and a peer group average near 27.75x. That headline discount might suggest a bargain, but it does not automatically account for Ingredion’s specific growth profile, margins, scale and risk factors.

Simply Wall St’s Fair Ratio metric aims to address this by estimating the PE multiple the company should trade on, given its earnings growth outlook, profitability, industry, market cap and risk characteristics. For Ingredion, the Fair Ratio is 13.73x, which sits between its current PE and the richer multiples of peers. Because this fair value anchor is materially higher than today’s 10.25x, the PE approach indicates that the shares may be undervalued on a risk adjusted basis.

Result: UNDERVALUED

NYSE:INGR PE Ratio as at Dec 2025
NYSE:INGR PE Ratio as at Dec 2025

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1450 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Ingredion Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way to connect your view of Ingredion’s story with a transparent financial forecast and a Fair Value estimate on Simply Wall St’s Community page, where investors share and compare ideas.

A Narrative is your structured story for a company, where you spell out what you think will happen to its revenues, earnings and margins. The platform then automatically turns that into a forecast and a Fair Value that you can compare with today’s share price as part of your decision to buy, hold or sell.

Because Narratives are dynamic, they update as new information, such as earnings releases or news, arrives. This helps your fair value view evolve instead of staying locked to a static report.

For example, one Ingredion investor might build a bullish Narrative that assumes health focused specialty ingredients keep growing and supports a Fair Value closer to a higher analyst target near $168. A more cautious investor could instead model weaker demand in legacy products and arrive nearer a lower value around $140. Both investors can clearly see how their assumptions drive those different valuations.

Do you think there's more to the story for Ingredion? Head over to our Community to see what others are saying!

NYSE:INGR 1-Year Stock Price Chart
NYSE:INGR 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Mobile Infrastructure for Defense and Disaster

The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.

Get the investor briefing before the next round of contracts

Sponsored On Behalf of CiTech

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:INGR

Ingredion

Manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries worldwide.

Flawless balance sheet established dividend payer.

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4034.1% undervalued
22 users have followed this narrative
1 users have commented on this narrative
5 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6089.9% undervalued
22 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8149.0% undervalued
43 users have followed this narrative
4 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Unicycive Therapeutics (Nasdaq: UNCY) – Preparing for a Second Shot at Bringing a New Kidney Treatment to Market (TEST)

Fair Value:US$21.5370.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KI
RKLB logo
KiwiInvest on Rocket Lab ·

Rocket Lab USA Will Ignite a 30% Revenue Growth Journey

Fair Value:US$97.8335.1% undervalued
137 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative
BA
Bauyrzhan
DG logo
Bauyrzhan on Dollar General ·

Dollar general to grow

Fair Value:US$158.916.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
120 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3927.7% undervalued
963 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8688.0% undervalued
78 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative